Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101). - Issa GC; Aldoss I; Thirman MJ; DiPersio J; Arellano M; Blachly JS; Mannis GN; Perl A; Dickens DS; McMahon CM; Traer E; Zwaan CM; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)